LIZA RODRIGUEZ: Open Payments
NPI 1306877519 · RED BANK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$185 in 11 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $232 · 2025 $185
Food & beverage: $185
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 5 | $92 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
| Braeburn Inc. | 1 | $16 |
| Alkermes, Inc. | 1 | $15 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
Products named: INGREZZA, COBENFY, CAPLYTA, BRIXADI, ARISTADA, REXULTI, AUSTEDO XR.
Industry payments across NJ — which companies pay providers there.
